|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Investments, at fair value | |||||||||||||||
| Non-Control/Non-Affiliate investments | |||||||||||||||
| Affiliate investments | |||||||||||||||
| Control investments | |||||||||||||||
| Total investments, at fair value | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Restricted cash and cash equivalents | |||||||||||||||
| Cash | |||||||||||||||
| Restricted cash | |||||||||||||||
| Cash equivalents | |||||||||||||||
| Interest receivable, net | |||||||||||||||
| Due from administrative agent | |||||||||||||||
| Deferred financing costs, net | |||||||||||||||
| Other assets, net | |||||||||||||||
| TOTAL ASSETS | |||||||||||||||
| LIABILITIES | |||||||||||||||
| Line of credit at fair value (Cost of $177,500 and $0, respectively) | |||||||||||||||
| Notes payable, net of unamortized deferred financing costs and discounts of $7,117 and $8,644, respectively | |||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||
| Interest payable | |||||||||||||||
| Fees due to related party | |||||||||||||||
| Total fees due to related party | |||||||||||||||
| Other liabilities | |||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||
| Preferred stock, $0.001 par value per share, 6,000,000 and 6,000,000 shares authorized, respectively, and 2,012,911 and 865,452 shares issued and outstanding, respectively | |||||||||||||||
| NET ASSETS | |||||||||||||||
| Common stock, $0.001 par value per share, 44,000,000 and 44,000,000 shares authorized, respectively, and 22,593,069 and 22,593,069 shares issued and outstanding, respectively | |||||||||||||||
| Capital in excess of par value | |||||||||||||||
| Cumulative net unrealized appreciation (depreciation) of investments | |||||||||||||||
| Cumulative net unrealized appreciation of other | |||||||||||||||
| Under distributed net investment income | |||||||||||||||
| Accumulated net realized gains (losses) | |||||||||||||||
| Accumulated net realized losses | |||||||||||||||
| Total distributable loss | |||||||||||||||
| TOTAL NET ASSETS | |||||||||||||||
| NET ASSET VALUE PER COMMON SHARE (in USD per share) | |||||||||||||||
Loading...
